Enhancement of host resistance against Trypanosoma cruzi infection by the immunoregulatory agent muramyl dipeptide
about
Immunostimulant activities of a lipophilic muramyl dipeptide derivative and of desmuramyl peptidolipid analogs.Effects of treatment with muramyl dipeptide and certain of its analogs on resistance to Listeria monocytogenes in mice.Prevention of oncogenic viral infections in mice with CGP 11637, a synthetic muramyl dipeptide analog.Activation of macrophages for enhanced release of superoxide anion and greater killing of Candida albicans by injection of muramyl dipeptide.Protective effect of muramyl dipeptide analogs against infections of Pseudomonas aeruginosa or Candida albicans in mice.Correlation between in vivo anti-Pseudomonas and anti-Candida activities and clearance of carbon by the reticuloendothelial system for various muramyl dipeptide analogs, using normal and immunosuppressed mice.Effects of muramyl dipeptide treatment on resistance to infection with Toxoplasma gondii in miceUveitis induction in the rabbit by muramyl dipeptidesSynergistic effect of glucantime and a liposome-encapsulated muramyl dipeptide analog in therapy of experimental visceral leishmaniasis.Marked enhancement in vivo of adjuvant activity of muramyl dipeptide to protein antigens and to synthetic weak immunogens with monoclonal anti-muramyl dipeptide antibodies.Synergistic effects of romurtide and cefmenoxime against experimental Klebsiella pneumonia in mice.Stimulation of complement production in mice by N alpha-(N-acetylmuramyl-L-alanyl-D-isoglutamine)-N epsilon-stearoyl-L-lysine.Treatment of Klebsiella pneumoniae septicemia in normal and leukopenic mice by liposome-encapsulated muramyl tripeptide phosphatidylethanolamide.Stimulation of resistance of immunocompromised mice by a muramyl dipeptide analog.Polymorphonuclear leukocyte activation by a synthetic muramyl dipeptide analog.
P2860
Q33900509-C245C269-F79A-49C8-85A2-2FA408115BA7Q33910568-684505AA-ED98-4772-BC6F-D5CD9373C8EDQ35572178-B35C8CA7-72FC-411E-9D82-38788E6FC5EFQ36344254-17DDA26A-620C-42A9-898C-C54B2F685A7EQ36431289-8D6E2DCF-A2EA-4FFA-904B-1CA415E5F624Q36433792-5A7D0543-E9F4-4094-BCB5-64E47E31989EQ36443048-9392F596-72CC-41F8-86B0-92D4E7C184D7Q37028172-D0F4A255-7EF4-4975-A26B-D14278B1F827Q37035564-53948EAB-5081-4E3C-AA1C-FBD3D3319755Q37049985-918D7481-21AC-4F0D-8D00-9092749AC178Q39870991-C3AB1A1E-9DA2-44CE-A7CB-090E04F037C6Q40182443-25087BB5-7F11-402A-94B4-909E9DAA1A3EQ40284852-ECCFB582-4E77-4049-843D-EFE1ECDA0D93Q40598634-D1489674-7132-4079-BF90-758AA9E81876Q40599272-DD619FDB-6FD5-41AE-B498-E30129CA9FE5
P2860
Enhancement of host resistance against Trypanosoma cruzi infection by the immunoregulatory agent muramyl dipeptide
description
1979 nî lūn-bûn
@nan
1979 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1979 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
name
Enhancement of host resistance ...... latory agent muramyl dipeptide
@ast
Enhancement of host resistance ...... latory agent muramyl dipeptide
@en
Enhancement of host resistance ...... latory agent muramyl dipeptide
@nl
type
label
Enhancement of host resistance ...... latory agent muramyl dipeptide
@ast
Enhancement of host resistance ...... latory agent muramyl dipeptide
@en
Enhancement of host resistance ...... latory agent muramyl dipeptide
@nl
prefLabel
Enhancement of host resistance ...... latory agent muramyl dipeptide
@ast
Enhancement of host resistance ...... latory agent muramyl dipeptide
@en
Enhancement of host resistance ...... latory agent muramyl dipeptide
@nl
P2860
P1476
Enhancement of host resistance ...... latory agent muramyl dipeptide
@en
P2093
Ferraresi RW
Kireszenbaum F
P2860
P304
P407
P577
1979-07-01T00:00:00Z